Fresenius Medical Care | FME - 税前利润

金融业

EUR

EUR 31.29B

现金及等价物

EUR 1.06B

EUR 3.55B

EUR 7.69B

EUR 7.18B

EUR 10.96B

股息收益率

3.76

EUR 480.55M

EUR 843.66M

112.38K

EPS每股收益

EUR 1.12

股本和储备

EUR 13.53B

EUR 1.31B

债务利息支出

EUR 83M

EUR 14.7M

EUR 5.82B

EUR 11.76B

EUR 218.38M

EUR 4.32B

EUR 537.27M

普通股股本

EUR 266.11M

12.13

EUR 383M

EUR 4.86B

销售和管理费用

EUR 736.01M

EUR 2.33B

贸易债权人

EUR 891.84M

应收帐款人

EUR 3.47B

	税前利润	更改		日
Akzo Nobel	EUR 148M		598M	2026-03
Alcon AG	USD 240M		24M	2026-03
AstraZeneca	USD 4.81B		894M	2026-06
Bayer	EUR 321M		2.67B	2026-06
Beiersdorf	EUR 408.5M		43.5M	2025-06
DaVita Healthcare Partners	USD 435.01M		93.78M	2026-06
Demant	DKK 1.64B		173M	2025-12
E.ON	EUR 3.63B		2.44B	2026-03
Essilor	EUR 2.64B		196M	2026-06
Fresenius	EUR 535M		42M	2026-06
Fresenius Medical Care	EUR 383M		43M	2026-06
Genmab	DKK 295M		221M	2026-06
Getinge	SEK 428M		1.54B	2025-03
Givaudan	CHF 642M		292M	2024-12
GlaxoSmithKline	GBP 2.68B		532M	2026-06
GN Store Nord	DKK -281M		280M	2026-06
GRIFOLS	EUR 247M		135M	2026-06
Hikma Pharmaceutical	USD 147.5M		3.5M	2025-06
Lonza	CHF 624M		197M	2024-12
Merck	EUR 869M		468M	2026-03
Novartis	USD 4.27B		430M	2026-06
Philips	EUR 546M		356M	2026-06
Roche Holding	CHF 11.17B		6.38B	2026-06
RWE	EUR 150M		677M	2026-03
Sanofi	EUR 837M		1.17B	2026-06
SAP	EUR 2.83B		65M	2026-03
Smith & Nephew	USD 469M		70M	2025-12